Ziai Wendy C, Torbey Michel T, Naff Neal J, Williams Michael A, Bullock Ross, Marmarou Anthony, Tuhrim Stanley, Schmutzhard Eric, Pfausler Bettina, Hanley Daniel F
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Cerebrovasc Dis. 2009;27(4):403-10. doi: 10.1159/000209241. Epub 2009 Mar 18.
Elevated intracranial pressure (ICP) is an important marker of neurological deterioration. The occurrence and significance of elevated ICP and low cerebral perfusion pressure (CPP) in aggressively treated spontaneous intraventricular hemorrhage (IVH) are not defined.
We performed a secondary longitudinal exploratory data analysis of a randomized multicenter trial of urokinase (UK) versus placebo (Pcb) as a treatment for IVH. Eleven IVH patients who required an external ventricular drain (EVD) were randomized to receive either intraventricular UK or Pcb every 12 h until clinical response permitted EVD removal. ICP and CPP were recorded every 4 or 6 h, as well as before and 1 h after EVD closure for administration of study agent. ICP, CPP and the proportion of ICP readings above 20, 30, 40 and 50 mm Hg were analyzed.
Six UK and 5 Pcb patients aged 39-74 years (mean +/- standard deviation; 53 +/- 11 years) were enrolled. Initial ICP ranged from 0 to 38 mm Hg (10.9 +/- 11.0), initial CPP from 65 to 133 mm Hg (100.5 +/- 17.7). We recorded 472 ICP readings over the entire monitoring period. Of these 65 (14%) were >20 mm Hg, 23 (5%) >30 mm Hg, 9 (2%) >40 mm Hg and 3 (<1%) >50 mm Hg. Only 2 of 141 intraventricular injections of study agent with EVD closure were not tolerated and required reopening of the EVD.
In the intensive care unit, initial ICP measured with an EVD was uncommonly elevated (1/11 patients) in this group of severe IVH patients despite acute obstructive hydrocephalus. Frequent monitoring reveals ICP elevation >20 mm Hg in 14% of observations during use of EVD. ICP elevation, though it can occur, is not routinely associated with EVD closure for thrombolytic treatment with UK.
颅内压(ICP)升高是神经功能恶化的重要标志。积极治疗的自发性脑室内出血(IVH)中ICP升高和脑灌注压(CPP)降低的发生情况及意义尚不明确。
我们对一项关于尿激酶(UK)与安慰剂(Pcb)治疗IVH的随机多中心试验进行了二次纵向探索性数据分析。11例需要外置脑室引流(EVD)的IVH患者被随机分组,每12小时接受一次脑室内UK或Pcb治疗,直至临床反应允许拔除EVD。每4或6小时记录一次ICP和CPP,以及在EVD关闭以给予研究药物之前和之后1小时记录。分析了ICP、CPP以及ICP读数高于20、30、40和50 mmHg的比例。
纳入了6例接受UK治疗和5例接受Pcb治疗的患者,年龄39 - 74岁(平均±标准差;53±11岁)。初始ICP范围为0至38 mmHg(10.9±11.0),初始CPP为65至133 mmHg(100.5±17.7)。在整个监测期间共记录了472次ICP读数。其中65次(14%)>20 mmHg,23次(5%)>30 mmHg,9次(2%)>40 mmHg,3次(<1%)>50 mmHg。在141次EVD关闭时脑室内注射研究药物的操作中,只有2次无法耐受,需要重新打开EVD。
在重症监护病房,尽管存在急性梗阻性脑积水,但在这组严重IVH患者中,用EVD测量的初始ICP很少升高(11例患者中有1例)。频繁监测发现,在使用EVD期间,14%的观察结果显示ICP升高>20 mmHg。ICP升高虽然可能发生,但在使用UK进行溶栓治疗时,与EVD关闭并无常规关联。